NCT03219450 A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. Status RECRUITING Phase PHASE1
NCT02410733 Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma Status COMPLETED Phase PHASE1
NCT02149225 GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients Status COMPLETED Phase PHASE1